Neoadjuvant T-VEC in High Risk Early Melanoma
Clinical trial NCT04427306 · SUSPENDED
Trial details
- NCT number
- NCT04427306
- Sponsor
- University of California, Davis
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2022-06-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.